USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS

The present invention relates to (lR,5S)-(+)-l-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane and pharmaceutical compositions thereof, and methods employing their use in the treatment of conditions affected by monoamine neurotransmitters, including ADHD and substance abuse. La présente invention concer...

Full description

Saved in:
Bibliographic Details
Main Authors BYMASTER, FRANK, MCKINNEY, ANTHONY ALEXANDER
Format Patent
LanguageEnglish
French
Published 18.05.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to (lR,5S)-(+)-l-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane and pharmaceutical compositions thereof, and methods employing their use in the treatment of conditions affected by monoamine neurotransmitters, including ADHD and substance abuse. La présente invention concerne le (lR,5S)-(+)-l-(naphthalèn-2-yl)-3-azabicyclo[3.1.0]hexane et des compositions à base de celui-ci, ainsi que leurs méthodes d'utilisation dans le cadre du traitement d'affections associées aux neurotransmetteurs mono-amine, parmi lesquelles le trouble d'hyperactivité avec déficit de l'attention et l'abus d'alcool ou d'autres drogues.
Bibliography:Application Number: CA20122843847